First Flu Shot Ships in the U.S.

GSK plc today announced it has started shipping doses of its quadrivalent influenza vaccines to U.S. healthcare providers and pharmacies in preparation for the 2023-24 flu season.

GSK stated in a press release on July 13, 2023, that it expects to distribute over 40 million doses of its influenza vaccine to the U.S. market.

During the last flu season, over 170 million influenza vaccines were distributed in the U.S.

Both FLULAVAL QUADRIVALENT and FLUARIX QUADRIVALENT will be available in a 0.5mL, single-dose, pre-filled syringe, and are indicated for patients six months and older.

The U.S. CDC recommends an annual flu vaccination for anyone aged six months and older who does not have contraindications.

Regarding when to get a flu shot in 2023, the CDC suggests people speak with a doctor, nurse, or pharmacist about which influenza vaccine is best for their needs and co-administration options.